West Paces Advisors Inc. Biogen Inc. Transaction History

West Paces Advisors Inc.

$408 Billion
Q3 2024

A detailed history of West Paces Advisors Inc. transactions in Biogen Inc. stock. As of the latest transaction made, West Paces Advisors Inc. holds 70 shares of BIIB stock, worth $9,691. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 70 -0.0%

Holding current value

$9,691

Previous $16.2 Million 16.38%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$212.02 - $267.71 $212 - $267	-1 Reduced 1.41%	70 $15.1 Million
Q4 2023 Jan 30, 2024	BUY	$222.59 - $267.94 $222 - $267	1 Added 1.43%	71 $18.4 Million
Q4 2022 Dec 18, 2023	BUY	$252.44 - $306.72 $17,670 - $21,470	70 New	70 $19.4 Million
Q4 2021 Dec 19, 2023	SELL	$223.92 - $287.77 $4,478 - $5,755	-20 Reduced 22.22%	70 $16.8 Million
Q3 2021 Dec 19, 2023	SELL	$282.99 - $369.05 $14,149 - $18,452	-50 Reduced 35.71%	90 $25.5 Million
Q1 2021 Dec 19, 2023	BUY	$242.95 - $284.63 $12,147 - $14,231	50 Added 55.56%	140 $39.2 Million
Q2 2020 Dec 19, 2023	BUY	$258.66 - $342.55 $5,173 - $6,851	20 Added 28.57%	90 $24.1 Million
Q1 2020 Dec 20, 2023	SELL	$268.85 - $341.04 $10,754 - $13,641	-40 Reduced 30.77%	90 $28.5 Million
Q4 2019 Dec 21, 2023	SELL	$220.06 - $304.07 $220 - $304	-1 Reduced 0.88%	112 $33.2 Million
Q3 2019 Dec 21, 2023	SELL	$217.44 - $243.88 $2,826 - $3,170	-13 Reduced 10.32%	113 $26.3 Million
Q2 2019 Dec 21, 2023	SELL	$219.29 - $241.72 $877 - $966	-4 Reduced 3.08%	126 $29.5 Million
Q3 2018 Dec 20, 2023	BUY	$293.51 - $383.83 $17,610 - $23,029	60 Added 85.71%	130 $45.9 Million
Q2 2018 Dec 21, 2023	BUY	$257.52 - $306.91 $1,030 - $1,227	4 Added 3.17%	130 $37.7 Million
Q4 2016 Dec 21, 2023	BUY	N/A	56	126 $35.7 Million

Others Institutions Holding BIIB

# of Institutions

996

Shares Held

129M

Call Options Held

1.37M

Put Options Held

1.51M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $19.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.

Account

West Paces Advisors Inc. Biogen Inc. Transaction History